Avanos Medical (AVNS) Cash from Investing Activities (2013 - 2026)

Avanos Medical has disclosed Cash from Investing Activities across 14 years of filings, most recently posting -$7.7 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 15.38% year-over-year to -$7.7 million; the TTM figure through Mar 2026 stood at -$59.2 million (down 71.1% YoY), while the FY2025 annual figure was -$60.6 million, down 120.36% from the prior year.
• Cash from Investing Activities came in at -$7.7 million for Q1 2026 at Avanos Medical, down from -$6.8 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $81.0 million in Q4 2023 to a low of -$121.7 million in Q1 2022.
• Average Cash from Investing Activities over 5 years is -$12.3 million, with a median of -$6.8 million recorded in 2025.
• Year-over-year, Cash from Investing Activities plunged 2035.09% in 2022 and soared 1753.06% in 2023.
• Over 5 years, Cash from Investing Activities stood at -$4.9 million in 2022, then soared by 1753.06% to $81.0 million in 2023, then sank by 109.38% to -$7.6 million in 2024, then rose by 10.53% to -$6.8 million in 2025, then slipped by 13.24% to -$7.7 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$7.7 million in Q1 2026, -$6.8 million in Q4 2025, and -$31.5 million in Q3 2025.